http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BG-104880-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ac40e7aead52a7105c7cb0309cf4668
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-714
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-245
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-714
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-568
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P21-04
filingDate 2000-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05d910818e1abd8930b03543526d51ca
publicationDate 2002-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BG-104880-A
titleOfInvention MEDICAMENTE TREATMENT FOR DISEASE TREATMENT / MULTIPLE / SCLEROSIS
abstract The drug is used to treat multiple sclerosis. The composition includes the following components in mg: zinc chlorate from 10.00 to 400.00, sodium salicylate from 1000.00 to 2000.00, nivalin from 5.00 to 20.00; Vitamins B12 from 1000.00 to 6000.00 g, B1 from 30.00 to 100.00, B2 from 5.00 to 20.00, B6 from 50.00 to 100.00, folic acid from 10.00 to 30 , 00, estriol (for females) from 0 to 1.00, testosterone (for men) respectively from 10.00 to 50.00, procaine (newcaine) from 20.00 to 80.00. The drug is injected intramuscularly into tightly defined areas, the occipital and sacral region, bilaterally.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EA-009209-B1
priorityDate 2000-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9651
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449288622
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419505226
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6013
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447475885
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507084
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449191261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16760658
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419481798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5795
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419552576
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25206
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5756

Total number of triples: 52.